MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis

MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1

(2011) William CS Cho et al.   RNA Biology

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

(2010) T Chiyomaru et al.   BRITISH JOURNAL OF CANCER

Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene

(2010) Jianjun Zhang et al.   CANCER

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

(2010) Zhe Chen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MiR-145, a new regulator of the DNA Fragmentation Factor-45 (DFF45)-mediated apoptotic network

(2010) Jianjun Zhang et al.   Molecular Cancer

miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness

(2010) M Götte et al.   ONCOGENE

MicroRNA-145 Targets YES and STAT1 in Colon Cancer Cells

(2010) Lea H. Gregersen et al.   PLoS One

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

(2009) Greg M Arndt et al.   BMC CANCER

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma

(2009) H-C Chen et al.   BRITISH JOURNAL OF CANCER

MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1

(2009) M. Sachdeva et al.   CANCER RESEARCH

MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells

(2009) Na Xu et al.   CELL

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells

(2009) R Spizzo et al.   CELL DEATH AND DIFFERENTIATION

Uncovering Growth-Suppressive MicroRNAs in Lung Cancer

(2009) X. Liu et al.   CLINICAL CANCER RESEARCH

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

(2009) M. Xin et al.   GENES & DEVELOPMENT

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

(2009) Takahiro Ichimi et al.   INTERNATIONAL JOURNAL OF CANCER

Modulation of microRNA processing by p53

(2009) Hiroshi I. Suzuki et al.   NATURE

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

(2009) M S Ostenfeld et al.   ONCOGENE

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

(2009) G L Semenza   ONCOGENE

The microRNA network and tumor metastasis

(2009) H Zhang et al.   ONCOGENE

Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers

(2009) Takeshi Takagi et al.   ONCOLOGY

miR-145 directs intestinal maturation in zebrafish

(2009) L. Zeng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

p53 represses c-Myc through induction of the tumor suppressor miR-145

(2009) M. Sachdeva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1

(2009) Erik Larsson et al.   Genome Medicine

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Endothelial p70 S6 Kinase 1 in Regulating Tumor Angiogenesis

(2008) L.-Z. Liu et al.   CANCER RESEARCH

Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion

(2008) T. Schmid et al.   CANCER RESEARCH

Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer

(2008) T. Schepeler et al.   CANCER RESEARCH

mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy

(2008) Paolo Baldo et al.   CURRENT CANCER DRUG TARGETS

Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment

(2008) Bing-Hua Jiang et al.   DRUG RESISTANCE UPDATES

Suppression of Programmed Cell Death 4 (PDCD4) Protein Expression by BCR-ABL-regulated Engagement of the mTOR/p70 S6 Kinase Pathway

(2008) Nathalie Carayol et al.   JOURNAL OF BIOLOGICAL CHEMISTRY